{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T05:51:32Z","timestamp":1789105892536,"version":"build-2803163510"},"reference-count":172,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Advances"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jacadv.2025.101784","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T11:10:55Z","timestamp":1747221055000},"page":"101784","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"P1","title":["Cardiac Amyloidosis in Older Adults With a Focus on Frailty"],"prefix":"10.1016","volume":"4","author":[{"given":"Nicole K.","family":"Bart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3673-0104","authenticated-orcid":false,"given":"Giada","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A.M.","family":"Cuddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7474-3737","authenticated-orcid":false,"given":"Parag","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1729-7464","authenticated-orcid":false,"given":"Jan M.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott L.","family":"Hummel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Macdonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyn","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Nanne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4297-6306","authenticated-orcid":false,"given":"Ariela R.","family":"Orkaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaishali","family":"Sanchorawala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8774-6416","authenticated-orcid":false,"given":"Abdulla A.","family":"Damluji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jacadv.2025.101784_bib1","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1186\/s12877-022-03404-w","article-title":"Frailty and risks of all-cause and cause-specific death in community-dwelling adults: a systematic review and meta-analysis","volume":"22","author":"Peng","year":"2022","journal-title":"BMC Geriatr"},{"issue":"3","key":"10.1016\/j.jacadv.2025.101784_bib2","doi-asserted-by":"crossref","first-page":"xi","DOI":"10.1016\/j.cger.2017.05.001","article-title":"The new geriatric giants","volume":"33","author":"Morley","year":"2017","journal-title":"Clin Geriatr Med"},{"issue":"1","key":"10.1016\/j.jacadv.2025.101784_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healun.2023.09.013","article-title":"Assessing and managing frailty in advanced heart failure: an International Society for Heart and Lung Transplantation consensus statement","volume":"43","author":"Denfeld","year":"2024","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jacadv.2025.101784_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1082371","article-title":"The role of frailty in advanced HF and cardiac transplantation","volume":"10","author":"Bart","year":"2023","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.jacadv.2025.101784_bib5","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.121.011669","article-title":"The influence of frailty on cardiovascular disease: the time for a \u201cFrailty Academic Research Consortium\u201d is now!","volume":"15","author":"Damluji","year":"2022","journal-title":"Circ Cardiovasc Interv"},{"issue":"9","key":"10.1016\/j.jacadv.2025.101784_bib6","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1001\/jama.2024.0442","article-title":"Cardiac amyloidosis due to transthyretin protein: a review","volume":"331","author":"Ruberg","year":"2024","journal-title":"Jama"},{"issue":"21","key":"10.1016\/j.jacadv.2025.101784_bib7","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1001\/jama.2024.4467","article-title":"Cardiovascular burden of the V142I transthyretin variant","volume":"331","author":"Selvaraj","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.jacadv.2025.101784_bib8","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.cardfail.2024.04.019","article-title":"Unlocking diversity in cardiovascular clinical research: lessons from the screening for cardiac amyloidosis with nuclear imaging in a minority populations study","volume":"30","author":"Wardhere","year":"2024","journal-title":"J Card Fail"},{"issue":"12","key":"10.1016\/j.jacadv.2025.101784_bib9","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1002\/ejhf.2532","article-title":"Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies","volume":"24","author":"Aimo","year":"2022","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"10.1016\/j.jacadv.2025.101784_bib10","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/jamacardio.2016.2839","article-title":"Multicenter study of planar technetium 99m pyrophosphate cardiac imaging: predicting survival for patients with ATTR cardiac amyloidosis","volume":"1","author":"Castano","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"2","key":"10.1016\/j.jacadv.2025.101784_bib11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jchf.2013.11.004","article-title":"Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction","volume":"2","author":"Mohammed","year":"2014","journal-title":"JACC Heart Fail"},{"issue":"3","key":"10.1016\/j.jacadv.2025.101784_bib12","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/07853890701842988","article-title":"Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study","volume":"40","author":"Tanskanen","year":"2008","journal-title":"Ann Med"},{"issue":"11","key":"10.1016\/j.jacadv.2025.101784_bib13","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2022.11.022","article-title":"2023 ACC Expert Consensus Decision Pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis","volume":"81","author":"Kittleson","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.jacadv.2025.101784_bib14","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging","volume":"153","author":"L\u00f3pez-Ot\u00edn","year":"2013","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.jacadv.2025.101784_bib15","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jchf.2024.02.021","article-title":"Aging in heart failure","volume":"12","author":"Goyal","year":"2024","journal-title":"JACC Heart Fail"},{"issue":"1","key":"10.1016\/j.jacadv.2025.101784_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cell.2005.01.018","article-title":"The biological and chemical basis for tissue-selective amyloid disease","volume":"121","author":"Sekijima","year":"2005","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.jacadv.2025.101784_bib17","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1096\/fj.11-189571","article-title":"Why are some amyloidoses systemic? Does hepatic \u201cchaperoning at a distance\u201d prevent cardiac deposition in a transgenic model of human senile systemic (transthyretin) amyloidosis?","volume":"26","author":"Buxbaum","year":"2012","journal-title":"FASEB J"},{"issue":"1","key":"10.1016\/j.jacadv.2025.101784_bib18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41572-018-0034-3","article-title":"Systemic immunoglobulin light chain amyloidosis","volume":"4","author":"Merlini","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"10.1016\/j.jacadv.2025.101784_bib19","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.hoc.2020.08.001","article-title":"Systemic amyloidosis due to clonal plasma cell diseases","volume":"34","author":"Bianchi","year":"2020","journal-title":"Hematol Oncol Clin North Am"},{"issue":"24","key":"10.1016\/j.jacadv.2025.101784_bib20","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMra2304088","article-title":"Systemic light chain amyloidosis","volume":"390","author":"Sanchorawala","year":"2024","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jacadv.2025.101784_bib21","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/ejh.13681","article-title":"Impact of time to diagnosis on Mayo stages, treatment outcome, and survival in patients with AL amyloidosis and cardiac involvement","volume":"107","author":"Oubari","year":"2021","journal-title":"Eur J Haematol"},{"issue":"12","key":"10.1016\/j.jacadv.2025.101784_bib22","doi-asserted-by":"crossref","first-page":"4248","DOI":"10.18632\/aging.101707","article-title":"How I treat elderly patients with plasma cell dyscrasias","volume":"10","author":"Gavriatopoulou","year":"2018","journal-title":"Aging (Albany NY)"},{"issue":"2","key":"10.1016\/j.jacadv.2025.101784_bib23","first-page":"87","article-title":"Comprehensive geriatric assessment: toward understanding its efficacy","volume":"1","author":"Rubenstein","year":"1989","journal-title":"Aging (Milano)"},{"issue":"1","key":"10.1016\/j.jacadv.2025.101784_bib24","first-page":"39","article-title":"Optimizing geriatric care with the GERIATRIC 5Ms","volume":"65","author":"Molnar","year":"2019","journal-title":"Can Fam Physician"},{"issue":"8","key":"10.1016\/j.jacadv.2025.101784_bib25","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jcin.2024.01.284","article-title":"Chronological vs biological age in interventional cardiology: a comprehensive approach to care for older adults: JACC Family Series","volume":"17","author":"Damluji","year":"2024","journal-title":"JACC Cardiovasc Interv"},{"issue":"4","key":"10.1016\/j.jacadv.2025.101784_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2024.100877","article-title":"TAVR in older adults: moving toward a comprehensive geriatric assessment and away from chronological age: JACC Family Series","volume":"3","author":"Damluji","year":"2024","journal-title":"JACC Adv"},{"issue":"4","key":"10.1016\/j.jacadv.2025.101784_bib27","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.033594","article-title":"Role of cognitive frailty in older adults with cardiovascular disease","volume":"13","author":"Ijaz","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacadv.2025.101784_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1276370","article-title":"Beyond MACE: a multidimensional approach to outcomes in clinical trials for older adults with stable ischemic heart disease","volume":"10","author":"Kalra","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jacadv.2025.101784_bib29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1750-1172-9-61","article-title":"THAOS: gastrointestinal manifestations of transthyretin amyloidosis - common complications of a rare disease","volume":"9","author":"Wixner","year":"2014","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"10.1016\/j.jacadv.2025.101784_bib30","doi-asserted-by":"crossref","DOI":"10.1111\/nan.12996","article-title":"Skeletal muscle involvement in systemic amyloidosis is often overlooked","volume":"50","author":"Xu","year":"2024","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"6","key":"10.1016\/j.jacadv.2025.101784_bib31","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/ehf2.12387","article-title":"Skeletal muscle wasting in chronic heart failure","volume":"5","author":"Suzuki","year":"2018","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jacadv.2025.101784_bib32","series-title":"World Report on Ageing and Health","year":"2015"},{"issue":"5","key":"10.1016\/j.jacadv.2025.101784_bib33","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jacc.2021.11.029","article-title":"Interventions for frailty among older adults with cardiovascular disease: JACC State-of-the-Art Review","volume":"79","author":"Ijaz","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.jacadv.2025.101784_bib34","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.008105","article-title":"Prevalence and prognostic significance of frailty among patients with transthyretin amyloidosis cardiomyopathy","volume":"14","author":"Fine","year":"2021","journal-title":"Circ Heart Fail"},{"issue":"6","key":"10.1016\/j.jacadv.2025.101784_bib35","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jacc.2017.06.024","article-title":"Frailty in older adults undergoing aortic valve replacement: the FRAILTY-AVR study","volume":"70","author":"Afilalo","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.jacadv.2025.101784_bib36","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s12603-012-0084-2","article-title":"A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans","volume":"16","author":"Morley","year":"2012","journal-title":"J Nutr Health Aging"},{"key":"10.1016\/j.jacadv.2025.101784_bib37","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1100\/tsw.2002.861","article-title":"The accumulation of deficits with age and possible invariants of aging","volume":"2","author":"Mitnitski","year":"2002","journal-title":"ScientificWorldJournal"},{"issue":"7","key":"10.1016\/j.jacadv.2025.101784_bib38","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1093\/gerona\/62.7.722","article-title":"Frailty in relation to the accumulation of deficits","volume":"62","author":"Rockwood","year":"2007","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"10.1016\/j.jacadv.2025.101784_bib39","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s40520-024-02750-6","article-title":"Determinants of health status in older patients with transthyretin cardiac amyloidosis: a prospective cohort study","volume":"36","author":"Fumagalli","year":"2024","journal-title":"Aging Clin Exp Res"},{"issue":"3","key":"10.1016\/j.jacadv.2025.101784_bib40","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"15","key":"10.1016\/j.jacadv.2025.101784_bib41","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.3390\/jcm10153415","article-title":"Frailty in wild-type transthyretin cardiac amyloidosis: the tip of the iceberg","volume":"10","author":"Broussier","year":"2021","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.jacadv.2025.101784_bib42","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/jama.2010.1923","article-title":"Gait speed and survival in older adults","volume":"305","author":"Studenski","year":"2011","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jacadv.2025.101784_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13506129.2022.2091985","article-title":"Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial","volume":"30","author":"Adams","year":"2023","journal-title":"Amyloid"},{"issue":"5","key":"10.1016\/j.jacadv.2025.101784_bib44","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s40120-023-00522-4","article-title":"Impact of vutrisiran on quality of life and physical function in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy","volume":"12","author":"Obici","year":"2023","journal-title":"Neurol Ther"},{"issue":"2","key":"10.1016\/j.jacadv.2025.101784_bib45","doi-asserted-by":"crossref","first-page":"M85","DOI":"10.1093\/geronj\/49.2.M85","article-title":"A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission","volume":"49","author":"Guralnik","year":"1994","journal-title":"J Gerontol"},{"issue":"9","key":"10.1016\/j.jacadv.2025.101784_bib46","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJM199503023320902","article-title":"Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability","volume":"332","author":"Guralnik","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacadv.2025.101784_bib47","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1471-2318-10-57","article-title":"A frailty instrument for primary care: findings from the Survey of Health, Ageing and Retirement in Europe (SHARE)","volume":"10","author":"Romero-Ortuno","year":"2010","journal-title":"BMC Geriatr"},{"issue":"5","key":"10.1016\/j.jacadv.2025.101784_bib48","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jamda.2009.11.003","article-title":"The tilburg frailty indicator: psychometric properties","volume":"11","author":"Gobbens","year":"2010","journal-title":"J Am Med Dir Assoc"},{"issue":"8","key":"10.1016\/j.jacadv.2025.101784_bib49","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1093\/annonc\/mdr587","article-title":"Screening older cancer patients: first evaluation of the G-8 geriatric screening tool","volume":"23","author":"Bellera","year":"2012","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.jacadv.2025.101784_bib50","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/SPC.0000000000000027","article-title":"Frailty and prognosis in advanced heart failure","volume":"8","author":"Boxer","year":"2014","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.jacadv.2025.101784_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2022.805501","article-title":"Associations between frailty and inflammation, physical, and psycho-social health in older adults: a systematic review","volume":"13","author":"Pothier","year":"2022","journal-title":"Front Psychol"},{"issue":"20","key":"10.1016\/j.jacadv.2025.101784_bib52","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1161\/CIRCULATIONAHA.123.064071","article-title":"Sarcopenia and cardiovascular diseases","volume":"147","author":"Damluji","year":"2023","journal-title":"Circulation"},{"issue":"Suppl 1","key":"10.1016\/j.jacadv.2025.101784_bib53","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1093\/gerona\/glu057","article-title":"Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases","volume":"69","author":"Franceschi","year":"2014","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jacadv.2025.101784_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arr.2016.08.006","article-title":"Inflammation and frailty in the elderly: a systematic review and meta-analysis","volume":"31","author":"Soysal","year":"2016","journal-title":"Ageing Res Rev"},{"issue":"12","key":"10.1016\/j.jacadv.2025.101784_bib55","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","article-title":"Chronic inflammation in the etiology of disease across the life span","volume":"25","author":"Furman","year":"2019","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.jacadv.2025.101784_bib56","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s10020-018-0047-0","article-title":"Serum amyloid A - a review","volume":"24","author":"Sack","year":"2018","journal-title":"Mol Med"},{"issue":"40","key":"10.1016\/j.jacadv.2025.101784_bib57","doi-asserted-by":"crossref","first-page":"16115","DOI":"10.1073\/pnas.1306621110","article-title":"Pathogenetic mechanisms of amyloid A amyloidosis","volume":"110","author":"Simons","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"22","key":"10.1016\/j.jacadv.2025.101784_bib58","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","article-title":"Transthyretin amyloid cardiomyopathy: JACC State-of-the-Art Review","volume":"73","author":"Ruberg","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.jacadv.2025.101784_bib59","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1161\/CIRCULATIONAHA.111.078915","article-title":"Transthyretin (TTR) cardiac amyloidosis","volume":"126","author":"Ruberg","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacadv.2025.101784_bib60","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev.nutr.22.010402.102715","article-title":"Sarcopenia, weight loss, and nutritional frailty in the elderly","volume":"22","author":"Bales","year":"2002","journal-title":"Annu Rev Nutr"},{"issue":"2","key":"10.1016\/j.jacadv.2025.101784_bib61","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nrcardio.2014.165","article-title":"Pathophysiology and treatment of cardiac amyloidosis","volume":"12","author":"Gertz","year":"2015","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"10.1016\/j.jacadv.2025.101784_bib62","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s12603-013-0437-5","article-title":"Cognitive frailty: rational and definition from an (I.a.N.a.\/i.a.g.g.) international consensus group","volume":"18","author":"Dartigues","year":"2014","journal-title":"J Nutr Health Aging"},{"issue":"3","key":"10.1016\/j.jacadv.2025.101784_bib63","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s12603-014-0535-z","article-title":"Cognitive aspects of frailty: mechanisms behind the link between frailty and cognitive impairment","volume":"19","author":"Halil","year":"2015","journal-title":"J Nutr Health Aging"},{"issue":"1","key":"10.1016\/j.jacadv.2025.101784_bib64","doi-asserted-by":"crossref","first-page":"42","DOI":"10.14283\/jpad.2017.29","article-title":"Cognitive Frailty and incidence of dementia in older persons","volume":"5","author":"Shimada","year":"2018","journal-title":"J Prev Alzheimers Dis"},{"issue":"2","key":"10.1016\/j.jacadv.2025.101784_bib65","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1097\/TP.0000000000001975","article-title":"Atrial fibrillation and central nervous complications in liver transplanted hereditary transthyretin amyloidosis patients","volume":"102","author":"Wange","year":"2018","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.jacadv.2025.101784_bib66","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMra023144","article-title":"Molecular mechanisms of amyloidosis","volume":"349","author":"Merlini","year":"2003","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jacadv.2025.101784_bib67","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.cardfail.2017.04.007","article-title":"Cognitive impairment and heart failure: systematic review and meta-analysis","volume":"23","author":"Cannon","year":"2017","journal-title":"J Card Fail"},{"issue":"6","key":"10.1016\/j.jacadv.2025.101784_bib68","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2176","article-title":"Cerebral blood flow impairment and cognitive decline in heart failure","volume":"11","author":"Ovsenik","year":"2021","journal-title":"Brain and Behavior"},{"issue":"11","key":"10.1016\/j.jacadv.2025.101784_bib69","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1111\/jgs.14471","article-title":"Unrecognized cognitive impairment and its effect on heart failure readmissions of elderly adults","volume":"64","author":"Agarwal","year":"2016","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"10.1016\/j.jacadv.2025.101784_bib70","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/ehf2.14188","article-title":"SGLT2 inhibitor therapy for transthyretin amyloid cardiomyopathy: early tolerance and clinical response to dapagliflozin","volume":"10","author":"Dobner","year":"2023","journal-title":"ESC Heart Fail"},{"issue":"3","key":"10.1016\/j.jacadv.2025.101784_bib71","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12603-010-0045-6","article-title":"Towards an integral conceptual model of frailty","volume":"14","author":"Gobbens","year":"2010","journal-title":"J Nutr Health Aging"},{"key":"10.1016\/j.jacadv.2025.101784_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2022.1066224","article-title":"Prevalence of anxiety and depression symptoms in a sample of outpatients with ATTR cardiac amyloidosis","volume":"13","author":"Smorti","year":"2023","journal-title":"Front Psychol"},{"issue":"11","key":"10.1016\/j.jacadv.2025.101784_bib73","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1002\/ejhf.1865","article-title":"Depression and heart failure: the lonely comorbidity","volume":"22","author":"Sbolli","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10.1016\/j.jacadv.2025.101784_bib74","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s10433-017-0414-7","article-title":"Social frailty in older adults: a scoping review","volume":"14","author":"Bunt","year":"2017","journal-title":"Eur J Ageing"},{"issue":"12","key":"10.1016\/j.jacadv.2025.101784_bib75","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1001\/jamapsychiatry.2016.2657","article-title":"Association of higher cortical amyloid burden with loneliness in cognitively normal older adults","volume":"73","author":"Donovan","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.jacadv.2025.101784_bib76","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s41687-020-00273-y","article-title":"Patient-reported burden of hereditary transthyretin amyloidosis on functioning and well-being","volume":"5","author":"Lovley","year":"2021","journal-title":"J Patient Rep Outcomes"},{"key":"10.1016\/j.jacadv.2025.101784_bib77","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2147\/RMHP.S168750","article-title":"Frailty syndrome: implications and challenges for health care policy","volume":"12","author":"Kojima","year":"2019","journal-title":"Risk Manag Healthc Policy"},{"issue":"1","key":"10.1016\/j.jacadv.2025.101784_bib78","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.4081\/hpr.2016.5578","article-title":"The impact of socioeconomic conditions, social networks, and health on frail older people's life satisfaction: a cross-sectional study","volume":"4","author":"Berglund","year":"2016","journal-title":"Health Psychol Res"},{"issue":"9","key":"10.1016\/j.jacadv.2025.101784_bib79","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.jcin.2012.06.011","article-title":"The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single-center experience","volume":"5","author":"Green","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"issue":"8","key":"10.1016\/j.jacadv.2025.101784_bib80","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jacc.2013.09.070","article-title":"Frailty assessment in the cardiovascular care of older adults","volume":"63","author":"Afilalo","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.jacadv.2025.101784_bib81","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/jcsm.13149","article-title":"Diagnostic test accuracy of ultrasound for sarcopenia diagnosis: a systematic review and meta-analysis","volume":"14","author":"Fu","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"2","key":"10.1016\/j.jacadv.2025.101784_bib82","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1056\/NEJMoa2305434","article-title":"Efficacy and safety of acoramidis in transthyretin amyloid cardiomyopathy","volume":"390","author":"Gillmore","year":"2024","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.jacadv.2025.101784_bib83","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1056\/NEJMoa2300757","article-title":"Patisiran treatment in patients with transthyretin cardiac amyloidosis","volume":"389","author":"Maurer","year":"2023","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.jacadv.2025.101784_bib84","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.jacadv.2025.101784_bib85","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1001\/jama.2023.18688","article-title":"Eplontersen for hereditary transthyretin amyloidosis with polyneuropathy","volume":"330","author":"Coelho","year":"2023","journal-title":"JAMA"},{"issue":"27","key":"10.1016\/j.jacadv.2025.101784_bib86","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.jacadv.2025.101784_bib87","doi-asserted-by":"crossref","first-page":"98","DOI":"10.14797\/mdcj-12-2-98","article-title":"Coming of age: considerations in the prescription of exercise for older adults","volume":"12","author":"Zaleski","year":"2016","journal-title":"Methodist Debakey Cardiovasc J"},{"issue":"3","key":"10.1016\/j.jacadv.2025.101784_bib88","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa2026141","article-title":"Physical rehabilitation for older patients hospitalized for heart failure","volume":"385","author":"Kitzman","year":"2021","journal-title":"N Eng J Med"},{"issue":"2","key":"10.1016\/j.jacadv.2025.101784_bib89","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.pcad.2014.07.004","article-title":"Therapeutic interventions for frail elderly patients: part I. Published randomized trials","volume":"57","author":"Bibas","year":"2014","journal-title":"Prog Cardiovasc Dis"},{"issue":"8","key":"10.1016\/j.jacadv.2025.101784_bib90","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1249\/mss.0b013e3180616aa2","article-title":"Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association","volume":"39","author":"Nelson","year":"2007","journal-title":"Med Sci Sports Exerc"},{"issue":"6","key":"10.1016\/j.jacadv.2025.101784_bib91","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jsams.2011.04.001","article-title":"Exercise and Sports Science Australia position statement on exercise and falls prevention in older people","volume":"14","author":"Tiedemann","year":"2011","journal-title":"J Sci Med Sport"},{"key":"10.1016\/j.jacadv.2025.101784_bib92","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pcad.2021.01.005","article-title":"Prioritizing movement to address the frailty phenotype in heart failure","volume":"67","author":"Laddu","year":"2021","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.jacadv.2025.101784_bib93","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.863179","article-title":"Assessment and management of older patients with transthyretin amyloidosis cardiomyopathy: geriatric cardiology, frailty assessment and beyond","volume":"9","author":"Irabor","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"17","key":"10.1016\/j.jacadv.2025.101784_bib94","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"32","key":"10.1016\/j.jacadv.2025.101784_bib95","doi-asserted-by":"crossref","first-page":"5289","DOI":"10.2174\/0929867329666220408102051","article-title":"Exploring the recent trends in management of dementia and frailty: focus on diagnosis and treatment","volume":"29","author":"Rahman","year":"2022","journal-title":"Curr Med Chem"},{"issue":"2","key":"10.1016\/j.jacadv.2025.101784_bib96","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3390\/ijerph20021088","article-title":"The effects of exercise for cognitive function in older adults: a systematic review and meta-analysis of randomized controlled trials","volume":"20","author":"Xu","year":"2023","journal-title":"Int J Environ Res Public Health"},{"issue":"6","key":"10.1016\/j.jacadv.2025.101784_bib97","first-page":"i","article-title":"Polypharmacy: a global risk factor for elderly people","volume":"6","author":"Dagli","year":"2014","journal-title":"J Int Oral Health"},{"issue":"7","key":"10.1016\/j.jacadv.2025.101784_bib98","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1111\/jgs.18372","article-title":"American Geriatrics Society 2023 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults","volume":"71","year":"2023","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"10.1016\/j.jacadv.2025.101784_bib99","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jaccao.2021.06.006","article-title":"ATTR amyloidosis: current and emerging management strategies","volume":"3","author":"Griffin","year":"2021","journal-title":"JACC CardioOncology"},{"issue":"4","key":"10.1016\/j.jacadv.2025.101784_bib100","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/ejhf.3198","article-title":"Sodium-glucose cotransporter 2 inhibitors for transthyretin amyloid cardiomyopathy: analyses of short-term efficacy and safety","volume":"26","author":"Lang","year":"2024","journal-title":"Eur J Heart Fail"},{"issue":"24","key":"10.1016\/j.jacadv.2025.101784_bib101","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.022859","article-title":"Lack of association between neurohormonal blockade and survival in transthyretin cardiac amyloidosis","volume":"10","author":"Cheng","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"24","key":"10.1016\/j.jacadv.2025.101784_bib102","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.jacc.2024.03.429","article-title":"SGLT2 inhibitor therapy in patients with transthyretin amyloid cardiomyopathy","volume":"83","author":"Porcari","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"31","key":"10.1016\/j.jacadv.2025.101784_bib103","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehad347","article-title":"Conventional heart failure therapy in cardiac ATTR amyloidosis","volume":"44","author":"Ioannou","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacadv.2025.101784_bib104","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10286-019-00623-x","article-title":"Orthostatic hypotension in hereditary transthyretin amyloidosis: epidemiology, diagnosis and management","volume":"29","author":"Palma","year":"2019","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.jacadv.2025.101784_bib105","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3389\/fphys.2019.00791","article-title":"Coexisting frailty with heart failure","volume":"10","author":"Uchmanowicz","year":"2019","journal-title":"Front Physiol"},{"issue":"10","key":"10.1016\/j.jacadv.2025.101784_bib106","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/eurjhf\/hft071","article-title":"Preferences of heart failure patients in daily clinical practice: quality of life or longevity?","volume":"15","author":"Kraai","year":"2013","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10.1016\/j.jacadv.2025.101784_bib107","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10433-017-0438-z","article-title":"What is the duration of life expectancy in the state of frailty? Estimates in the SIPAF study","volume":"15","author":"Herr","year":"2018","journal-title":"Eur J Ageing"},{"issue":"8","key":"10.1016\/j.jacadv.2025.101784_bib108","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/gerona\/gly232","article-title":"The burden of frailty among U.S. Veterans and its association with mortality, 2002-2012","volume":"74","author":"Orkaby","year":"2019","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"10.1016\/j.jacadv.2025.101784_bib109","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/jgs.17468","article-title":"Life expectancy estimates based on comorbidities and frailty to inform preventive care","volume":"70","author":"Schoenborn","year":"2022","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"10.1016\/j.jacadv.2025.101784_bib111","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/jgs.17011","article-title":"Heterogeneity of aging: individual risk factors, mechanisms, patient priorities, and outcomes","volume":"69","author":"Ferrucci","year":"2021","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"10.1016\/j.jacadv.2025.101784_bib112","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF02982161","article-title":"The I.A.N.A Task Force on frailty assessment of older people in clinical practice","volume":"12","author":"Abellan van Kan","year":"2008","journal-title":"J Nutr Health Aging"},{"key":"10.1016\/j.jacadv.2025.101784_bib113","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1093\/eurheartj\/ehad885","article-title":"Changes in frailty and incident cardiovascular disease in three prospective cohorts","volume":"45","author":"He","year":"2024","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.jacadv.2025.101784_bib114","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1213\/ANE.0000000000004785","article-title":"Prehabilitation for the frailty syndrome: improving outcomes for our most vulnerable patients","volume":"130","author":"Norris","year":"2020","journal-title":"Anesth Analg"},{"issue":"14","key":"10.1016\/j.jacadv.2025.101784_bib115","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.3390\/jcm13144169","article-title":"A comprehensive geriatric workup and frailty assessment in older patients with severe aortic stenosis","volume":"13","author":"Brunetti","year":"2024","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.jacadv.2025.101784_bib116","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1001\/jamainternmed.2018.6738","article-title":"Evaluation of changes in functional status in the year after aortic valve replacement","volume":"179","author":"Kim","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.jacadv.2025.101784_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2022.100160","article-title":"The multidisciplinary heart team in cardiovascular medicine: current role and future challenges","volume":"2","author":"Batchelor","year":"2023","journal-title":"JACC Adv"},{"issue":"3","key":"10.1016\/j.jacadv.2025.101784_bib118","article-title":"Geriatric cardiology: coming of age","volume":"1","author":"Goyal","year":"2022","journal-title":"JACC Adv"},{"issue":"5","key":"10.1016\/j.jacadv.2025.101784_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2023.100421","article-title":"A geriatric approach to percutaneous coronary interventions in older adults, Part II: a JACC: Advances Expert Panel","volume":"2","author":"Nanna","year":"2023","journal-title":"JACC Adv"},{"issue":"1","key":"10.1016\/j.jacadv.2025.101784_bib120","first-page":"136","article-title":"A prospective study of nutritional status in immunoglobulin light chain amyloidosis","volume":"98","author":"Prayman","year":"2012","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.jacadv.2025.101784_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.currproblcancer.2021.100833","article-title":"Focused review on nutritional status of patients with immunoglobulin light chain amyloidosis","volume":"46","author":"Grigoletti","year":"2022","journal-title":"Curr Probl Cancer"},{"issue":"3","key":"10.1016\/j.jacadv.2025.101784_bib122","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1080\/13506129.2020.1737004","article-title":"Bioelectrical impedance vector analysis-derived phase angle predicts survival in patients with systemic immunoglobulin light-chain amyloidosis","volume":"27","author":"Caccialanza","year":"2020","journal-title":"Amyloid"},{"issue":"9","key":"10.1016\/j.jacadv.2025.101784_bib123","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.amjmed.2006.10.018","article-title":"Frailty: an emerging geriatric syndrome","volume":"120","author":"Ahmed","year":"2007","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.jacadv.2025.101784_bib124","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/gerona\/59.3.M255","article-title":"Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care","volume":"59","author":"Fried","year":"2004","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"5","key":"10.1016\/j.jacadv.2025.101784_bib125","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1182\/blood-2017-09-746420","article-title":"Frailty and the management of hematologic malignancies","volume":"131","author":"Abel","year":"2018","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.jacadv.2025.101784_bib126","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1182\/blood-2014-12-615187","article-title":"Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report","volume":"125","author":"Palumbo","year":"2015","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jacadv.2025.101784_bib127","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3324\/haematol.2016.162693","article-title":"A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients","volume":"102","author":"Engelhardt","year":"2017","journal-title":"Haematologica"},{"issue":"Supplement_1","key":"10.1016\/j.jacadv.2025.101784_bib128","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1182\/blood-2019-124468","article-title":"Fried frailty phenotype predicts mortality for newly diagnosed older patients with acute myeloid leukemia or high risk myelodysplastic syndrome","volume":"134","author":"McCurdy","year":"2019","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.jacadv.2025.101784_bib129","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.3390\/cancers16091689","article-title":"A simple frailty score predicts survival and early mortality in systemic AL amyloidosis","volume":"16","author":"Rios-Tamayo","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"18","key":"10.1016\/j.jacadv.2025.101784_bib130","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1200\/JCO.2004.03.029","article-title":"Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis","volume":"22","author":"Dispenzieri","year":"2004","journal-title":"J Clin Oncol"},{"issue":"17","key":"10.1016\/j.jacadv.2025.101784_bib131","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1182\/blood-2012-12-473066","article-title":"A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis","volume":"121","author":"Wechalekar","year":"2013","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.jacadv.2025.101784_bib132","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1200\/JCO.2011.38.5724","article-title":"Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements","volume":"30","author":"Kumar","year":"2012","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.jacadv.2025.101784_bib133","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/ajh.26641","article-title":"Predictors of hematologic response and survival with stem cell transplantation in AL amyloidosis: a 25-year longitudinal study","volume":"97","author":"Gustine","year":"2022","journal-title":"Am J Hematol"},{"issue":"13","key":"10.1016\/j.jacadv.2025.101784_bib134","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1200\/JCO.2017.76.9554","article-title":"Stem cell transplantation for light chain amyloidosis: decreased early mortality over time","volume":"36","author":"Sidiqi","year":"2018","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.jacadv.2025.101784_bib135","doi-asserted-by":"crossref","first-page":"e260","DOI":"10.3324\/haematol.2014.108191","article-title":"Stringent patient selection improves outcomes in systemic light-chain amyloidosis after autologous stem cell transplantation in the upfront and relapsed setting","volume":"99","author":"Venner","year":"2014","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.jacadv.2025.101784_bib136","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jaccao.2021.09.003","article-title":"AL amyloidosis: current chemotherapy and immune therapy treatment strategies: JACC: CardioOncology State-of-the-Art Review","volume":"3","author":"Bianchi","year":"2021","journal-title":"JACC CardioOncol"},{"issue":"11","key":"10.1016\/j.jacadv.2025.101784_bib137","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMoa070484","article-title":"High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis","volume":"357","author":"Jaccard","year":"2007","journal-title":"N Engl J Med"},{"issue":"32","key":"10.1016\/j.jacadv.2025.101784_bib138","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1200\/JCO.2015.62.4015","article-title":"Improved outcomes after autologous Hematopoietic cell transplantation for light chain amyloidosis: a Center for International Blood and Marrow Transplant Research Study","volume":"33","author":"D'Souza","year":"2015","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.jacadv.2025.101784_bib139","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.clml.2021.01.021","article-title":"Clinical characteristics, treatment regimens, and survival in elderly patients with AL amyloidosis","volume":"21","author":"Acevedo","year":"2021","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"12","key":"10.1016\/j.jacadv.2025.101784_bib140","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1182\/blood-2006-06-029728","article-title":"Successful treatment of AL amyloidosis with high-dose melphalan and autologous stem cell transplantation in patients over age 65","volume":"108","author":"Seldin","year":"2006","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jacadv.2025.101784_bib141","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1056\/NEJMoa2028631","article-title":"Daratumumab-based treatment for immunoglobulin light-chain amyloidosis","volume":"385","author":"Kastritis","year":"2021","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jacadv.2025.101784_bib142","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/bjh.18733","article-title":"First report of outcomes in patients with stage IIIb AL amyloidosis treated with Dara-VCD front-line therapy","volume":"201","author":"Chakraborty","year":"2023","journal-title":"Br J Haematol"},{"issue":"Supplement 1","key":"10.1016\/j.jacadv.2025.101784_bib143","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1182\/blood-2023-185811","article-title":"Efficacy and safety of daratumumab monotherapy in newly diagnosed patients with stage 3B light-chain amyloidosis: a phase 2 study by the European myeloma network","volume":"142","author":"Kastritis","year":"2023","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.jacadv.2025.101784_bib144","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14028","article-title":"United network for organ sharing outcomes after heart transplantation for al compared to ATTR cardiac amyloidosis","volume":"34","author":"Griffin","year":"2020","journal-title":"Clin Transplant"},{"issue":"2","key":"10.1016\/j.jacadv.2025.101784_bib145","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1182\/blood-2010-01-263236","article-title":"XBP1s levels are implicated in the biology and outcome of myeloma mediating different clinical outcomes to thalidomide-based treatments","volume":"116","author":"Bagratuni","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jacadv.2025.101784_bib146","doi-asserted-by":"crossref","DOI":"10.1177\/11795468211015230","article-title":"Best practices in specialized amyloidosis centers in the United States: a survey of cardiologists, nurses, patients, and patient advocates","volume":"15","author":"Nativi-Nicolau","year":"2021","journal-title":"Clin Med Insights Cardiol"},{"issue":"5","key":"10.1016\/j.jacadv.2025.101784_bib147","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1093\/eurjcn\/zvad009","article-title":"Integrated care in cardiovascular disease: a statement of the association of cardiovascular nursing and allied professions of the European Society of Cardiology","volume":"22","author":"Ski","year":"2023","journal-title":"Eur J Cardiovasc Nurs"},{"issue":"1","key":"10.1016\/j.jacadv.2025.101784_bib148","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s13643-023-02335-w","article-title":"The effectiveness of nurse-led interventions to manage frailty in community-dwelling older people: a systematic review","volume":"12","author":"Kasa","year":"2023","journal-title":"Systematic Reviews"},{"issue":"1","key":"10.1016\/j.jacadv.2025.101784_bib149","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13023-021-01812-6","article-title":"Psychosocial burden and professional and social support in patients with hereditary transthyretin amyloidosis (ATTRv) and their relatives in Italy","volume":"16","author":"Magliano","year":"2021","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.jacadv.2025.101784_bib150","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13023-024-03052-w","article-title":"Needs of amyloidosis patients and their care providers: design & first results of the AMY-NEEDS research and care program","volume":"19","author":"Ihne-Schubert","year":"2024","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"10.1016\/j.jacadv.2025.101784_bib151","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3390\/hemato3030028","article-title":"Functional impairments of amyloidosis patients: physical therapy assessment","volume":"3","author":"Redder","year":"2022","journal-title":"Hemato"},{"issue":"Suppl 1","key":"10.1016\/j.jacadv.2025.101784_bib152","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.amjcard.2022.10.053","article-title":"Care of patients with transthyretin amyloidosis: the roles of nutrition, supplements, exercise, and mental health","volume":"185","author":"Dasgupta","year":"2022","journal-title":"Am J Cardiol"},{"issue":"12","key":"10.1016\/j.jacadv.2025.101784_bib153","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1016\/j.jand.2018.03.004","article-title":"Academy of nutrition and dietetics evidence-based practice guideline for the management of heart failure in adults","volume":"118","author":"Kuehneman","year":"2018","journal-title":"J Acad Nutr Diet"},{"issue":"1","key":"10.1016\/j.jacadv.2025.101784_bib154","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1186\/s13023-023-02964-3","article-title":"Occupational practice in patients with hereditary transthyretin amyloidosis, a qualitative study","volume":"18","author":"Gay\u00e0-Barroso","year":"2023","journal-title":"Orphanet J Rare Dis"},{"issue":"18","key":"10.1016\/j.jacadv.2025.101784_bib155","doi-asserted-by":"crossref","first-page":"11721","DOI":"10.3390\/ijerph191811721","article-title":"Establishing occupational therapy needs: a semi-structured interview with hereditary transthyretin amyloidosis patients","volume":"19","author":"Gay\u00e0-Barroso","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"10.1016\/j.jacadv.2025.101784_bib156","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/TP.0000000000000991","article-title":"The prevalence and prognostic significance of frailty in patients with advanced heart failure referred for heart transplantation","volume":"100","author":"Jha","year":"2016","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.jacadv.2025.101784_bib157","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/TP.0000000000003669","article-title":"Validation of cognitive impairment in combination with physical frailty as a predictor of mortality in patients with advanced heart failure referred for heart transplantation","volume":"106","author":"Aili","year":"2022","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.jacadv.2025.101784_bib158","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.healun.2016.04.008","article-title":"Cognitive impairment improves the predictive validity of physical frailty for mortality in patients with advanced heart failure referred for heart transplantation","volume":"35","author":"Jha","year":"2016","journal-title":"J Heart Lung Transplant"},{"issue":"2","key":"10.1016\/j.jacadv.2025.101784_bib159","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.healun.2020.11.007","article-title":"The impact of frailty on mortality after heart transplantation","volume":"40","author":"Macdonald","year":"2021","journal-title":"J Heart Lung Transplant"},{"issue":"6","key":"10.1016\/j.jacadv.2025.101784_bib160","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.healun.2022.02.008","article-title":"Impact of frailty on mortality and morbidity in bridge to transplant recipients of contemporary durable mechanical circulatory support","volume":"41","author":"Muthiah","year":"2022","journal-title":"J Heart Lung Transplant"},{"issue":"4","key":"10.1016\/j.jacadv.2025.101784_bib161","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.healun.2013.12.014","article-title":"Frailty and outcomes after implantation of left ventricular assist device as destination therapy","volume":"33","author":"Dunlay","year":"2014","journal-title":"J Heart Lung Transplant"},{"issue":"5","key":"10.1016\/j.jacadv.2025.101784_bib162","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.cardfail.2014.02.008","article-title":"Reduced handgrip strength as a marker of frailty predicts clinical outcomes in patients with heart failure undergoing ventricular assist device placement","volume":"20","author":"Chung","year":"2014","journal-title":"J Card Fail"},{"issue":"11","key":"10.1016\/j.jacadv.2025.101784_bib163","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1111\/jgs.15124","article-title":"Can a left ventricular assist device in individuals with advanced systolic heart failure improve or reverse frailty?","volume":"65","author":"Maurer","year":"2017","journal-title":"J Am Geriatr Soc"},{"issue":"7","key":"10.1016\/j.jacadv.2025.101784_bib164","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000000690","article-title":"Reversibility of frailty after bridge-to-transplant ventricular assist device implantation or heart transplantation","volume":"3","author":"Jha","year":"2017","journal-title":"Transplant Direct"},{"issue":"1","key":"10.1016\/j.jacadv.2025.101784_bib165","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1253\/circj.CJ-21-0819","article-title":"Prevention and reversal of frailty in heart failure - a systematic review","volume":"86","author":"Aili","year":"2021","journal-title":"Circ J"},{"issue":"4","key":"10.1016\/j.jacadv.2025.101784_bib166","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001606","article-title":"The relationship between rehabilitation and frailty in advanced heart or lung disease","volume":"10","author":"Dinesh","year":"2024","journal-title":"Transplant Direct"},{"issue":"9","key":"10.1016\/j.jacadv.2025.101784_bib167","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s12603-019-1273-z","article-title":"Physical frailty: ICFSR international clinical practice guidelines for identification and management","volume":"23","author":"Dent","year":"2019","journal-title":"J Nutr Health Aging"},{"key":"10.1016\/j.jacadv.2025.101784_bib168","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101513","article-title":"Physical activity and exercise: strategies to manage frailty","volume":"35","author":"Angulo","year":"2020","journal-title":"Redox Biol"},{"issue":"1","key":"10.1016\/j.jacadv.2025.101784_bib169","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1186\/s12877-022-03370-3","article-title":"Exercise interventions for older people with cognitive frailty\u2014a scoping review","volume":"22","author":"Li","year":"2022","journal-title":"BMC Geriatrics"},{"key":"10.1016\/j.jacadv.2025.101784_bib170","article-title":"E-health StandingTall balance exercise for fall prevention in older people: results of a two year randomised controlled trial","volume":"373","author":"Delbaere","year":"2021","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.jacadv.2025.101784_bib171","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13274","article-title":"A mobile health technology enabled home-based intervention to treat frailty in adult lung transplant candidates: a pilot study","volume":"32","author":"Singer","year":"2018","journal-title":"Clin Transplant"},{"issue":"10","key":"10.1016\/j.jacadv.2025.101784_bib172","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.nut.2015.04.011","article-title":"Nutritional counseling improves quality of life and preserves body weight in systemic immunoglobulin light-chain (AL) amyloidosis","volume":"31","author":"Caccialanza","year":"2015","journal-title":"Nutrition"},{"key":"10.1016\/j.jacadv.2025.101784_bib173","article-title":"Advances in nutritional supplementation for sarcopenia management","volume":"10","author":"Liu","year":"2023","journal-title":"Front Nutr"}],"container-title":["JACC: Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X25002029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X25002029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T05:44:08Z","timestamp":1753335848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772963X25002029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":172,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2772963X25002029"],"URL":"https:\/\/doi.org\/10.1016\/j.jacadv.2025.101784","relation":{},"ISSN":["2772-963X"],"issn-type":[{"value":"2772-963X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac Amyloidosis in Older Adults With a Focus on Frailty","name":"articletitle","label":"Article Title"},{"value":"JACC: Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacadv.2025.101784","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"101784"}}